---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-017162"
form_type: "8-K"
ticker: "LCTX"
cik: "0000876343"
company_name: "Lineage Cell Therapeutics, Inc."
filed_at: "2022-06-17T23:59:59+00:00"
generated_at: "2026-06-25T01:04:22.385533+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Lineage Cell Therapeutics holds annual meeting; all director nominees elected, auditor ratified, say-on-pay approved

## Summary
- Elected nine directors: Kingsley, Amin, Andrews, Bailey, Bradsher, Culley, Jayasuriya, Mulroy, Russell.
- Ratified WithumSmith+Brown as auditor: 114.8M for, 0.5M against, 1.4M abstain.
- Advisory say-on-pay approved: 70.9M for, 1.8M against, 1.8M abstain.
- Broker non-votes of 42.2M on director elections and say-on-pay.

## SEC filing metadata
- accession: 0001493152-22-017162
- form_type: 8-K
- ticker: LCTX
- cik: 0000876343
- company_name: Lineage Cell Therapeutics, Inc.
- filed_at: 2022-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876343/000149315222017162/0001493152-22-017162-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876343/000149315222017162/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-017162
- JSON: https://secwatch.observer/filing/0001493152-22-017162.json
- Plain text: https://secwatch.observer/filing/0001493152-22-017162.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.